ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 2 filers reported holding ALBIREO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,693,886 | +40.5% | 217,209 | +25.8% | 1.91% | +75.2% |
| Q3 2022 | $3,342,000 | +345.0% | 172,621 | +356.2% | 1.09% | +313.7% |
| Q2 2022 | $751,000 | -79.2% | 37,835 | -68.7% | 0.26% | -72.3% |
| Q1 2022 | $3,604,000 | +135.7% | 120,834 | +84.1% | 0.95% | +157.2% |
| Q4 2021 | $1,529,000 | -58.2% | 65,638 | -44.1% | 0.37% | -55.8% |
| Q3 2021 | $3,661,000 | +0.5% | 117,328 | +13.3% | 0.83% | -16.7% |
| Q2 2021 | $3,642,000 | +0.1% | 103,512 | +0.3% | 1.00% | +5.6% |
| Q1 2021 | $3,637,000 | +129.3% | 103,175 | +144.0% | 0.95% | +65.7% |
| Q4 2020 | $1,586,000 | -8.9% | 42,292 | -18.9% | 0.57% | +11.1% |
| Q3 2020 | $1,740,000 | – | 52,131 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |